Venmax Drugs and Pharmaceuticals Ltd — Important, 30-07-2026: Company Update

The company has allotted 7,53,334 new equity shares to a non-promoter warrant holder upon conversion. These shares were issued at Rs. 20 each, bringing in an additional 1.13 Cr as the balance exercise price. This boosts the company's paid-up capital to 14.48 Cr, now comprising 1.45 Cr shares. Investors should note 7.80 lakh warrants are still pending conversion, signaling potential future equity expansion.